Citius Pharmaceuticals, Inc. CTXR
Set alert
0.55 USD -0.01 -2.53%
As of Nov 3, 2:31 PM ET
0.5201 Day range 0.56
0.37 52-week range 1.54
- YTD
- -29.50%
- 1 year
- -63.96%
- Open
- 0.56
- Prev close
- 0.562
- Mkt cap
- 15.04M
- Vol
- 23.40K
- Avg vol
- 473.08K
- EPS
- -1.75
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.5201
- High
- 0.56
- Forward P/E
- 15.32
- Beta
- 1.66
- Short ratio
- 1.23
- Inst. own
- 13.17%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Jan 3, 2025
- 50-d avg
- 6.51
- 200-d avg
- 14.50
- 1y target
- 54.00
3M chart
Signals (34)
| Name | Date | Ago |
|---|---|---|
| SMA: Bullish | Nov 2, 2026 | 1 day ago |
| SMA: Bearish | Oct 30, 2026 | 4 days ago |
| SMA: Bullish | Oct 28, 2026 | 6 days ago |
| SMA: Bullish | Oct 28, 2026 | 6 days ago |
| MACD: Buy Signal | Oct 27, 2026 | 1 week ago |
| RSI: Oversold | Oct 19, 2026 | 2 weeks ago |
| MACD: Sell Signal | Sep 28, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 25, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 24, 2026 | 1 month ago |
| SMA: Bearish | Sep 23, 2026 | 1 month ago |
| SMA: Bullish | Sep 22, 2026 | 1 month ago |
| SMA: Bearish | Sep 21, 2026 | 1 month ago |
| SMA: Bullish | Sep 18, 2026 | 1 month ago |
| MACD: Buy Signal | Sep 18, 2026 | 1 month ago |
| SMA: Bearish | Sep 9, 2026 | 1 month ago |
| SMA: Bullish | Sep 8, 2026 | 1 month ago |
| SMA: Bearish | Sep 4, 2026 | 2 months ago |
| SMA: Bullish | Sep 3, 2026 | 2 months ago |
| SMA: Bearish | Aug 31, 2026 | 2 months ago |
| SMA: Bearish | Aug 28, 2026 | 2 months ago |
Newest 20 of 34.
Analyst view
Price target (mean) 54.00 +9757.6% upside
Now 0.5478
- Target (low)
- 8.00
- Target (mean)
- 54.00
- Target (high)
- 100.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy2
- Buy0
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.50 | -2.00 – -1.00 | -1.75 | +14.3% | 0 | 0.0% | 2 |
| Next quarter | -1.25 | -1.25 – -1.25 | 0.00 | 0.0% | 7.06M | 0.0% | 1 |
| Current year | -5.63 | -6.50 – -4.75 | -5.50 | -2.3% | 0 | 0.0% | 2 |
| Next year | 0.125 | -4.50 – 4.75 | -5.63 | +102.2% | 39.59M | 0.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 22, 2024 | D. Boral Capital | Downgrade | Buy | Hold |
| Nov 12, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Nov 11, 2024 | D. Boral Capital | Maintained | Buy | Buy |
| Aug 19, 2024 | EF Hutton | Maintained | Buy | Buy |
| Aug 8, 2024 | EF Hutton | Maintained | Buy | Buy |
| Aug 5, 2024 | EF Hutton | Maintained | Buy | Buy |
| Jul 15, 2024 | EF Hutton | Initiated | — | Buy |
| May 31, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Feb 14, 2024 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 10, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Aug 1, 2023 | HC Wainwright & Co. | Maintained | Buy | Buy |
| May 30, 2023 | HC Wainwright & Co. | Reiterated | Buy | Buy |
| Apr 3, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Mar 29, 2023 | HC Wainwright & Co. | Reiterated | — | Buy |
| Jan 18, 2022 | HC Wainwright & Co. | Maintained | — | Buy |
| Nov 30, 2021 | Maxim Group | Initiated | — | Buy |
| May 23, 2018 | HC Wainwright & Co. | Initiated | — | Buy |